Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in Human Astrocytic and Oligodendroglial Gliomas

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3937-3944

  Thorns, V ^a   Walter, G F ^a   Thorns, C ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Astrocytoma; Glioblastoma; Immunohistochemistry; MMP; Oligodendroglioma

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; STROMELYSIN 2; STROMELYSIN 3;

ANAPLASTIC CARCINOMA; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER GRADING; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

ASTROCYTOMA; BRAIN NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 10; MATRIX METALLOPROTEINASE 11; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; METALLOENDOPEPTIDASES; OLIGODENDROGLIOMA;

EID: 0344442235     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Amberger VR, Hensel T, Ogata N and Schwab ME: Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res 58: 149-158, 1998.
2. Paganetti PA, Caroni P and Schwab ME: Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease. J Cell Biol 107: 2281-2291, 1988.
3. Nakano A, Tani E, Miyazaki K, Yamamoto Y and Furuyama J: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307, 1995.
4. Westermarck J and Kahari VM: Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13: 781-792, 1999.
5. Wild-Bode C, Weller M and Wick W: Molecular determinants of glioma cell migration and invasion. J Neurosurg 94: 978-984, 2001.
6. Nakada M, Kita D, Futami K, Yamashita J, Fujimoto N, Sato H and Okada Y: Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma. J Neurosurg 94: 464-473, 2001.
7. Kachra Z, Beaulieu E, Delbecchi L, Mousseau N, Berthelet F, Moumdjian R, Del Maestro R and Beliveau R: Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 17: 555-566, 1999.
8. Oh LY, Larsen PH, Krekoski CA, Edwards DR, Donovan F, Werb Z and Yong VW: Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19: 8464-8475, 1999.
9. Uhm JH, Dooley NP, Oh LY and Yong VW: Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22: 53-63, 1998.
10. Nabeshima K, Inoue T, Shimao Y and Sameshima T: Matrix metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 52: 255-264, 2002.
11. Yano H, Hara A, Murase S, Hayashi K, Shinoda J, Shimokawa K and Sakai N: Expression of hepatocyte growth factor and matrix metalloproteinase-2 in human glioma. Brain Tumor Pathol 18: 7-12, 2001.
12. Donahue B, Scott CB, Nelson JS, Rotman M, Murray KJ, Nelson DF, Banker FL, Earle JD, Fischbach JA, Asbell SO, Gaspar LE, Markoe AM and Curran W: Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 38: 911-914, 1997.
13. Kraus JA, Wenghoefer M, Schmidt MC, von Deimling A, Berweiler U, Roggendorf W, Diete S, Dietzmann K, Muller B, Heuser K, Reifenberger G and Schlegel U: Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation. J Neurol 247: 455-460, 2000.
14. Havemose-Poulsen A, Holmstrup P, Stoltze K and Birkedal-Hansen H: Dissolution of type I collagen fibrils by gingival fibroblasts isolated from patients of various periodontitis categories. J Periodontal Res 33: 280-291, 1998.
15. Birkedal-Hansen H: Matrix metalloproteinases. Adv Dent Res 9: 16, 1995.
16. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 728-735, 1995.
17. Lampert K, Machein U, Machein MR, Conca W, Peter HH and Volk B: Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 153: 429-437, 1998.
18. Vince GH, Wagner S, Pietsch T, Klein R, Goldbrunner RH, Roosen K and Tonn JC: Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas. Int J Dev Neurosci 17: 437-445, 1999.
19. Goldbrunner RH, Bernstein JJ, Plate KH, Vince GH, Roosen K and Tonn JC: Vascularization of human glioma spheroids implanted into rat cortex is conferred by two distinct mechanisms. J Neurosci Res 55: 486-495, 1999.
20. Zhang X, Yamashita M, Uetsuki H and Kakehi Y: Angiogenesis in renal cell carcinoma: Evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases. Int J Urol 509-514, 2002.
21. Collen A, Hanemaaijer R, Lupu F, Quax PH, Van Lent N, Grimbergen J, Peters E, Koolwijk P and Van Hinsbergh VW: Membrane-type matrix metalloproteinase mediated angiogenesis in a fibrin-collagen matrix. Blood: 2002.
22. Takahashi M, Fukami S, Iwata N, Inoue K, Itohara S, Itoh H, Haraoka J and Saido T: In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture. Pharmacol Res 46: 155-163, 2001.
23. Yoshida D, Noha M, Watanabe K, Sugisaki Y and Teramoto A: Novel approach to analysis of in vitro tumor angiogenesis with a variable-pressure scanning electron microscope: suppression by matrix metalloproteinase inhibitor SI-27. Brain Tumor Pathol 18: 89-100, 2001.
24. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T and Okada Y: Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J Neurosurg 81: 69-77, 1994.
25. Lakka SS, Rajan M, Gondi C, Yanamandra N, Chandrasekar N, Jasti SL, Adachi Y, Siddique K, Gujrati M, Olivero W, Dinh DH, Kouraklis G, Kyritsis AP and Rao JS: Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21: 8011-8019, 2002.
26. Watanabe K, Yoshida D, Noha M and Teramoto A: Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B. J Neurooncol 52: 1-9, 2001.
27. Rao JS, Yamamoto M, Mohaman S, Gokaslan ZL, Fuller GN, Stetler-Stevenson WG, Rao VH, Liotta LA, Nicolson GL, Sawaya RE: Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin Exp Metastasis 14: 12-18, 1996.
28. Franchi A, Santucci M, Masini E, Sardi I, Paglierani M and Gallo O: Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 95: 1902-1910, 2002.
29. Van Trappen PO, Ryan A, Carroll M, Lecoeur C, Goff L, Gyselman VG, Young BD, Lowe DG, Pepper MS, Shepherd JH and Jacobs IJ: A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer. Br J Cancer 87: 537-544, 1997.
30. Wilson CL, Heppner KJ, Labosky PA, Hogan BL and Matrisian LM: Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94: 1402-1407, 1997.
31. Heppner KJ, Matrisian LM, Jensen RA and Rodgers WH: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 149: 273-282, 1996.
32. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas. Anticancer Res 21: 2021-2028, 2001.
33. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Immunocytochemical detection of the expression of members of the matrix metalloproteinase family in adenocarcinomas of the pancreas. In Vivo 15: 71-76, 2001.
34. Bodey B, Bodey B Jr, Siegel SE and Kaiser HE: Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis. In Vivo 15: 57-64, 2001.
35. Furukawa A, Tsuji M, Nishitani M, Kanda K, Inoue Y, Kanayama H and Kagawa S: Role of the matrix metalloproteinase and tissue inhibitors of metalloproteinase families in noninvasive and invasive tumors transplanted in mice with severe combined immunodeficiency. Urology 51: 849-853, 1998.
36. Bodey B, Bodey B, Jr., Siegel SE and Kaiser HE: Matrix metalloproteinase expression in childhood medulloblastomas/ primitive neuroectodermal tumors. In Vivo 14: 667-673, 2000.
37. Kerkela E, Ala-aho R, Lohi J, Grenman R, Kahari V, Saarialho-Kere U: Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer 84: 659-669, 2001.
38. Bachmeier BE, Boukamp P, Lichtinghagen R, Fusenig NE and Fink E: Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines. Biol Chem 381: 497-507, 2000.
39. Perret AG, Duthel R, Fotso MJ, Brunon J and Mosnier JF: Stromelysin-3 is expressed by aggressive meningiomas. Cancer 94: 765-772, 2002.
40. Sreenath T, Matrisian LM, Stetler-Stevenson W, Gattoni-Celli S and Pozzatti RO: Expression of matrix metalloproteinase genes in transformed rat cell lines of high and low metastatic potential. Cancer Res 52: 4942-4947, 1992.
41. Cribier B, Noacco G, Peltre B and Grosshans E: Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans. J Am Acad Dermatol 46: 408-413, 2002.
42. Cribier B, Noacco G, Peltre B and Grosshans E: Expression of stromelysin 3 in basal cell carcinomas. Eur J Dermatol 11: 530-533, 2001.
43. Wang CS and Tetu B: Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction. Int J Cancer 99: 792-799, 2002.